E-DRUG Archives (by thread)

  • [e-drug] Products recalled in Australia, Libby Roughead
  • [e-drug] Data on Generic ARVs, Sunaina Sharma
  • [e-drug] Canadian study on drugs in the news - CMAJ article, Barbara Mintzes
  • [e-drug] Over 40 Swiss organizations launch access campaign, Julien Reinhard
  • [e-drug] MSF on malaria, E-drug
  • [e-drug] Drug registration, inspection and lab testing -please shareyour, sxp
  • [e-drug] Products recalled in Australia (cont'd), Sarah Sellers
  • [e-drug] WHO/EDM Technical Briefing Seminar, Hans V. Hogerzeil
  • [e-drug] 63rd Congress of FIP 2003, Teresa L. Alves
  • [e-drug] SARS gene patent application will help cure research, Horst Herb
  • [e-drug] General Accounting Review of Global Fund (con't), Warren Kaplan
  • [e-drug] Drug promotion tours, Vanda Zidoniene
  • [e-drug] Gefitinib approval and PMS in Japan, Rokuro Hama
  • [e-drug] Handwashing and diarrhoeal diseases, E-drug
  • [e-drug] Lifestyle drugs for pets, Staffan Svensson
  • [e-drug] Update on Drug Management Software Suite, Arin Speed
  • [e-drug] Alan Maynard and Karen Bloor on pharma expenditures, James Love
  • [e-drug] New WHO Model List on the web, Hans Hogerzeil
  • [e-drug] 2003 SEAM Conference Update, Arin Speed
  • [e-drug] New WHO Model List on the web (cont'd), Valeria Frighi
  • [e-drug] Query on essential drugs & blindness, Luis Miguel Bascones
  • [e-drug] Drug information service, Fionnuala Mc Cullagh
  • [e-drug] WHO's Information Exchange System, Shanthi Pal
  • [e-drug] Joint MSF/HAI/OXFAM letter to 56th WHA, Spring Gombe
  • [e-drug] JAMA Announcements, E-drug
  • [e-drug] Vacancy at HAI Europe, Kevin . Moody [kevin
  • [e-drug] Cost effectiveness of injection safety, Yvan Hutin
  • [e-drug] Review of Community Pharmacy Services, Libby Roughead
  • [e-drug] Preliminary announcement training course, Perla Mordujovich
  • [e-drug] UK support for drug price reductions in developing countries, E-drug
  • [e-drug] 25 years of the WHO essential medicines lists, E-drug
  • [e-drug] Drug price structure, Philippe Swennen
  • [e-drug] Panorama programme on Seroxat accessible but only until Sunday, marg
  • [e-drug] 25 years of the WHO essential medicines lists (cont'd), Richard Laing
  • [e-drug] G7 Finance Ministers meeting: Crisis at the Global Fund, Olivier Jablonski
  • [e-drug] Panorama programme on Seroxat accessible (cont'd), Joel Lexchin
  • [e-drug] Practical guide to bar coding for patient medication safety, Stein Lyftingsmo
  • [e-drug] HIV/AIDS and needle transmission in Sub-Saharan Africa, E-drug
  • [e-drug] Pharmaceutical Journal campaign for patient packs, Stein Lyftingsmo
  • [e-drug] Evaluation of drug information services, Geeta Pradeep
  • [e-drug] Australia shaken by complementary medicines recall, E-drug
  • [e-drug] Evaluation of drug information services (cont'd), Several E-druggers
  • [e-drug] Bar codes (cont'd), Brian Gunn
  • [e-drug] WHO and HAI launch new pricing study, Margaret Ewen
  • [e-drug] 21 May: MSF briefing in 56th WHA, Ingrid Cox
  • [e-drug] WHO on intellectual property rights, innovation and public health, james . love
  • [e-drug] WHO report on essential medicines, e-drug
  • [e-drug] Protease Inhibitors, Jim Prudhomme
  • [e-drug] June 2 World Bank Meeting on Generic drugs, James Love
  • [e-drug] WHO report on traditional medicines, e-drug
  • [e-drug] Drug price structure (cont'd), Kirsten Myhr
  • [e-drug] MSF briefing in 56th WHA (cont'd), Betty Mwingira
  • [e-drug] Guardian on WHO/HAI drug pricing report, e-drug
  • [e-drug] MSF report Drug Patents Under The Spotlight, Ingrid Cox
  • [e-drug] Re: WHO and HAI launch new pricing study (cont), Kirsten . Myhr [kirsten.myhr
  • [e-drug] Africa's Aids drugs trapped in the laboratory, e-drug
  • [e-drug] Pharmaceutical firms attacked over drug patents (1), Ingrid Cox
  • [e-drug] Pharmaceutical firms attacked over drug patents (2), Ingrid Cox
  • [e-drug] Pharmaceutical firms attacked over drug patents (3), Ingrid Cox
  • [e-drug] Pharmacists Against Tobacco: Session at WCTOH, Satu Tainio
  • [e-drug] Riskier Bayer drug sold overseas, E-drug
  • [e-drug] NYT: Bayer sold unsafe blood products, CBGnetwork
  • [e-drug] New WHO DG invites Brazilian AIDS expert to his team, e-drug
  • [e-drug] Course "Managing drug supply for primary health care", Julie Pasquier
  • [e-drug] From TRIPS to RIPS: A better Trade Framework, James Love
  • [e-drug] PRDU course, Swaziland, November 2003, Hans Hogerzeil
  • [e-drug] Course "Managing drug supply" (cont'd), Geeta Pradeep
  • [e-drug] Challenges to Scaling up antiretroviral treatment in Africa, David Haerry
  • [e-drug] New International Drug Price Indicator Guide Available, Julie McFadyen
  • [e-drug] Drug company sponsorship could easily be replaced, E-drug
  • [e-drug] Drug company secretly briefed medical societies on HRT, E-drug
  • [e-drug] Double standards in information should go, E-drug
  • [e-drug] Evidence b(i)ased medicine, E-drug
  • [e-drug] General practitioners and pharmaceutical industry info, E-drug
  • [e-drug] Pharmaceutical industry sponsorship, E-drug
  • [e-drug] WHA resolution on IPRs, Cecilia Oh
  • [e-drug] G8 downgrades access to medicines issue, e-drug
  • [e-drug] WHO Assembly analysis, Brook Baker
  • [e-drug] EU acts to speed up flow of cheap Aids drugs, e-drug
  • [e-drug] Unified licensure/regulation of pharmaceuticals & biologicals?, Niels Rosenquist
    • Mail converted by MHonArc 2.6.8